Novel Use of a1 AR Subtype-Selective Drugs in Patients with Acute Myocardial Infarction
The present invention relates to the use of α1aAR-selective and/or α1a/α1d-selective antagonists in a method of preventing restenosis after myocardial infarction and re-perfusion. The invention further relates to a method of identifying agents suitable for us in such a method.
Interested in this Technology?
Submit your interest below.